Cargando…
Megadose Methylprednisolone (MDMP) Treatment in a Patient with Autoimmune Hemolytic Anemia (AIHA) Resistant to Conventional Corticosteroid Administration: A Case Report
A female in the Netherlands with severe autoimmune hemolytic anemia (AIHA) was treated with conventional corticosteroid (2 mg/kg/d in divided doses) and blood transfusions for 18 months without improvement. The presented patient responded to megadose methylprednisolone (MDMP) 30 mg/kg/d for 3 d, fol...
Autores principales: | Özsoylu, Şinasi, Berenschot, Henriette WA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878473/ https://www.ncbi.nlm.nih.gov/pubmed/24385786 http://dx.doi.org/10.4274/Tjh.2012.0070 |
Ejemplares similares
-
Megadose Methyl-Prednisolone (MDMP) for Autoimmune Hemolytic Anemia
por: Özsoylu, Şinasi
Publicado: (2013) -
Megadose Methylprednisolone (MDMP) for Hemangiomatosis
por: Özsoylu, Şinasi
Publicado: (2012) -
Megadose Methylprednisolone (MDMP) For Granulocytic Sarcoma (GS)
por: ÖZSOYLU, Şinasi
Publicado: (2013) -
Megadose Methylprednisolone (MDMP) for Hemangiomatosis
por: Küpeli, Serhan, et al.
Publicado: (2012) -
A New Murine Model of Primary Autoimmune Hemolytic Anemia (AIHA)
por: Dei Zotti, Flavia, et al.
Publicado: (2021)